Ameritas Investment Partners, Inc. Eagle Pharmaceuticals, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.86 Billion
- Q1 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 867 shares of EGRX stock, worth $4,855. This represents 0.0% of its overall portfolio holdings.
Number of Shares
867
Previous 867
-0.0%
Holding current value
$4,855
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EGRX
# of Institutions
94Shares Held
10.4MCall Options Held
3KPut Options Held
36.3K-
Nantahala Capital Management, LLC New Canaan, CT1.26MShares$7.05 Million0.42% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.19MShares$6.64 Million2.51% of portfolio
-
Black Rock Inc. New York, NY898KShares$5.03 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT879KShares$4.92 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA641KShares$3.59 Million0.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $72.9M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...